GeneDx Holdings Stock Surges 8% on Strong Q2 Earnings

BTCC / BTCC Square / Global Cryptocurrency /

Author:

Release Time:

2025-07-30 06:49:01

BTCCSquare news:

GeneDx Holdings (WGS) saw its shares jump more than 8% after reporting robust second-quarter results, sharply outperforming the broader market's 0.3% decline. Revenue surged 49% year-over-year to $103 million, driven by a 69% increase in exome and genome testing sales. The company also flipped to an adjusted net income of $0.50 per share, far exceeding analyst estimates of $0.12.

Investors cheered the raised full-year guidance, signaling confidence in sustained growth. The genetic testing firm's outperformance highlights the market's appetite for healthcare innovators delivering both top-line expansion and profitability.

By:

Log in to Reply

Is Kyrgyzstan Fueling Russia’s Sanctions Evasion Through Crypto?

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.